A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is $90.62, with a 24-hour trading volume of $606.08M. The asset's market cap is $280.97B, after moving 0.01% in the last day.
Tokenized AstraZeneca PLC is trading at $90.71, with a tokenized market cap of $680.39K and a 24-hour trading volume of $70.33K. The tokenized asset has moved 0.33% in the past 24 hours.